Investigational medications in the treatment of alopecia.
Title
Investigational medications in the treatment of alopecia.
Creator
Poulos Georgann A; Mirmirani Paradi
Publisher
Expert opinion on investigational drugs
Date
2005
2005-02
Description
Androgenetic alopecia (hereditary thinning) is the most common cause of hair loss in both men and women. Chemotherapy-induced alopecia is another distressing cause of hair loss. With a better understanding of follicular biology and the signals responsible for hair growth and regression, targeted therapies for hair loss are being investigated. This review summarises investigational medications for androgenetic and chemotherapy-induced alopecia that are in preclinical stages or later.
Subject
Humans; Animals; Alopecia/chemically induced/*drug therapy/genetics; Androgen Antagonists/therapeutic use; Antineoplastic Agents/adverse effects/therapeutic use; Clinical Trials as Topic/methods; Drugs; Investigational/*therapeutic use
Identifier
Rights
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
Citation
Poulos Georgann A; Mirmirani Paradi, “Investigational medications in the treatment of alopecia.,” NEOMED Bibliography Database, accessed January 20, 2025, https://neomed.omeka.net/items/show/4980.